Emcure Pharma Q2 profit rises 25%, revenue up 13% on broad-based growth

Pune-based Emcure Pharmaceuticals reported a 13.4% year-on-year rise in consolidated revenue to ₹2,270 crore in the September quarter, supported by double-digit growth in both domestic and international markets. Net profit increased 24.7% YoY to ₹251 crore, while EBITDA rose 15.2% to ₹439 crore, with a margin of 19.3%, the company said on Tuesday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uUoaJhO
via IFTTT